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The transient receptor potential vanilloid 4 (TRPV4) cation channel, a member of the TRP vanilloid subfamily, is
expressed in a broad range of tissues. Nitric oxide (NO) as a gaseous signal mediator shows a variety of important
biological effects. In many instances, NO has been shown to exhibit its activities via a protein S-nitrosylation
mechanism in order to regulate its protein functions. With functional assays via site-directed mutagenesis, we
demonstrate herein that NO induces the S-nitrosylation of TRPV4 Ca
2 channel on the Cys
853 residue, and the
S-nitrosylation of Cys
853 reduced its channel sensitivity to 4-a phorbol 12,13-didecanoate and the interaction
between TRPV4 and calmodulin. A patch clamp experiment and Ca
2  image analysis show that the S-nitrosylation
of Cys
853 modulates the TRPV4 channel as an inhibitor. Thus, our data suggest a novel regulatory mechanism of
TRPV4 via NO-mediated S-nitrosylation on its Cys
853 residue.
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Introduction
The participation of transient receptor potential vanil-
loid 4 (TRPV4) in osmo- and mechanotransduction
contributes to important functions including cellular
and systemic volume homeostasis, arterial dilatation,
nociception, epithelial hydroelectrolyte transport, blad-
der voiding and the regulation of ciliary beat frequency
(Nilius et al. 2003; Cohen 2006; Vennekens et al. 2008;
Everaerts et al. 2009). TRPV4 also responds to tem-
perature, endogenous arachidonic acid (AA) metabo-
lites, and phorbol esters including the inactive 4-a
phorbol 12,13-didecanoate (4-a PDD), and also parti-
cipates in receptor-operated Ca
2  entry, evidencing
multiple activationmodes(Suzuki etal.2003a;Andrade
et al. 2005; Becker et al. 2005; Earley et al. 2005; Birder
et al. 2007). Therefore, the elucidation of important
molecular pathways that modulate TRPV4 transport
sensitivity has promoted our understanding of its
biological functions in the cell (Nilius et al. 2003; Cohen
2006;Vennekensetal.2008;Everaertsetal.2009).Inthis
regard,severalproteinshavebeenproposedtomodulate
TRPV4 subcellular localization and/or function: micro-
tubule-associated protein 7, calmodulin (CaM), OS-9,
actin, and pacsin3 (Strotmann et al. 2003; Suzuki et al.
2003b;Cuajungcoetal.2006;Fuetal.2006).Ithasbeen
reported that fairly intimate functional and physical
interactions occur between the inositol trisphosphate
receptor 3 (IP3R3) and TRPV4, which sensitize the
latter to the mechano- and osmotransducing messenger
5’,6’-epoxieicosatrienoic acid (Nilius et al. 2003; Cohen
2006;Birderetal.2007;Vennekensetal.2008;Everaerts
et al. 2009). Muramatsu et al. also demonstrated that
TRPV4 regulates the SOX9 [SRY (sex-related Y)-type
highmobilitygroupbox]pathwayandcontributestothe
process of chondrogenesis (Muramatsu et al. 2007)
Until now, only a little information has been
available concerning the molecular players responsible
for the processes regulating the sensitivityof TRPV4 for
Ca
2  flux (Watanabe et al. 2002, 2003; Fernandes et al.
2008). In this regard, a number of regulatory posttran-
slationalmodifications,includingphosphorylation,ubi-
quitinylation and glycosylation, have recently been
implicated in the control of the biophysical, pharmaco-
logical and expression properties of ion channels and
transporters via direct interactions (Fan et al. 2009,
Wegierski et al. 2009).
Nitric oxide (NO) is a pleiotropic cell signaling
molecule which controls a variety of biological pro-
cesses (Olson and Garba ´n 2008; Robertson and Sillar
2009). The importance of a protein S-nitrosylation
(a posttranslational modification in which a cysteinyl
thiol is converted to a nitrosothiol by NO) is being
increasingly recognized in the field of NO signal
transduction (Miyamoto et al. 2009). Even though
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NO-mediated regulatory mechanism of various classes
of proteins, the link between protein S-nitrosylation
and functional relevance has been proven only in
limited examples, and should be experimentally deter-
mined (Kimura et al. 2000; Gavathiotis et al. 2008;
Asada et al. 2009). The characterization of S-nitrosyla-
tion protein may provide a clue to further understand
the mechanism and the functional significance under-
lying the preferential S-nitrosylation of the target Cys.
This reversible posttranslational modification may
function as analogous to a protein phosphorylation
in the broad spectrum of cellular signal regulatory
mechanism of various classes of proteins (Haendeler
et al. 2004; Lipton 2007; Teixeira et al. 2008), including
ion channels such as the transient receptor potential
canonical 5 (TRPC5), the skeletal muscle type ryano-
dine receptor (ryanodine receptor type 1) channel, the
N-methyl-D-aspartate receptor channel, the cardiac L-
type Ca
2 channel, and the cardiac Na
  channel (Choi
et al. 2000; Sun et al. 2001, 2007; Yoshida et al. 2006).
In this paper, we have provided, for the first time,
evidence that the Cys
853 residue of TRPV4 is one of the
S-nitrosylation target sites by NO, as a preferential
target for its inactivation, which is presumably
mediated for the regulation of negative feedback in
HEK293 cells. Additionally, as compared with TRPV4
WT, the C853A mutant evidenced more sensitivity to
4-a PDD, with a higher level of cellular Ca
2  influx.
Materials and methods
Site-directed mutagenesis and plasmid construction
In order to generate the mutants, amino acid changes
Cys 853 Ala or Cys 645 Ala were introduced using
mutated oligonucleotides for C645A (up 5? aac atg
aag gtc GCt gac gag gac cag agc aac 3?,d o w n5 ? gct
ctg gtc ctc gtc aGC gac ctt cat gtt ggt 3?) or C853A (up
5? ggg aac ccc aac GCt gac ggc cac cag cag 3?,d o w n
5? ctg gtg gcc gtc aGC gtt ggg gtt ccc tag 3?) and
wild-type TRPV4 as a template. The TRPV4 mutant
constructs were prepared using the QuikChange XL
Site-Directed Mutagenesis Kit (Stratagene). In order to
acquired truncated TRPV4 (aa718 871), we used
primers (up 5? ata gga tcc atg ggt gag acc gtg ggc
cag 3?,d o w n5 ’ ata ctc gag cta cag tgg ggc atc gtc cgt 
3?). All TRPV4 mutants were confirmed via DNA
sequencing. To create the GST fusion protein (aa718 
871) TRPV4 WT cDNA or its C853 mutant were PCR
amplified, and were subcloned into the pGEX-5X-1
vector (Amersham). Human embryonic kidney (HEK
293) cells were transfected with TRPV4 and with
mutant constructs as described previously.
Preparation of GST fusion protein and biotin-switch
assay
GST fusion proteins were purified as previously
described. In brief, the expression of GST fusion
proteins in Escherichia coli strain BL21 (DE3) (RBC)
was induced with 0.1 mM isopropyl 1-thio-b-D-galac-
topyranoside overnight at 18 208C. Cells were har-
vested via centrifugation and were re-suspended in lysis
buffer (50 mM Tris, pH 7.5, 100 mM NaCl, 5 mM
EDTA). Cell lysis was achieved by treating the cells
with lysozyme (1 mg/ml) for 1 h on ice, sonicating them
with 1.5% Sarkosyl, and then subjecting them to a
freeze-thaw cycle. Soluble fractions from a 10-min
centrifugation at 24,000 g (48C) were rotated for 1
h in the presence of GST-Sepharose beads (Amersham
Biosciences) at 48C. Beads containing bound fusion
proteins in HEN buffer (100 mM HEPES, pH 7.7, 400
mM EDTA, 40 mM neocuproine) were incubated with 1
mM S-nitroso-N-acetyl penicillamine (SNAP) for 1 h
at a room temperature, and SNAP was removed by five
washings with HEN buffer.
The biotin-switch assay was conducted as pre-
viously described by Jaffrey et al. In brief, GST fusion
proteins immobilized to GST-Sepharose beads were
washed with HEN buffer containing 0.05% Triton
X-100, and free thiol (R-SH) residues were blocked
(R-S-S-CH3) for 30 min with 20 mM methylmetha-
nethiol sulfonate (MMTS, Sigma-Aldrich) in HEN
buffer containing 2.5% SDS at 538C. After 1 min of
centrifugation at 2500 rpm (at room temperature), the
supernatant was incubated for 30 min at -208C with
two volumes of pre-chilled acetone to remove MMTS.
Only S-nitrosylated thiol (R-S-NO) residues were then
reduced to free thiol (R-SH) with 1 mM sodium
ascorbate in HEN buffer and were biotinylated (R-
S-S-biotin) with 4 mM biotin-HPDP (Pierce). The
biotinylated samples were subsequently electrophor-
esed in SDS-polyacrylamide gel, transferred to a
polyvinylidene difluoride membrane (Amersham Bios-
ciences), and immunoblotted with a 1:4000-diluted
monoclonal anti-biotin antibody (BN-34, Sigma-
Aldrich). The proteins were detected with an advanced
enhanced chemiluminescence system (Amersham
Biosciences) using a LAS-3000 mini lumino-image
analyzer (Fujifilm, Japan).
Fluorescence measurements of [Ca
2]i
We measured [Ca
2 ]i using the fluorescent Ca
2 
indicator Fluo4-acetoxymethyl ester (Fluo4-AM) as
previously described. In brief, cells growing on cover-
slips were incubated for 40 min in a DMSO solution
containing 1 M Fluo4-AM at 248C in darkness,
then washed and incubated for 15 min to hydrolyze
96 E.J. Lee et al.internalized Fluo4-AM. We measured [Ca
2 ]i in single
cells that emitted fluorescence, using confocal micro-
scopy (LSM710 Zeiss, Germany). The absorption (as
arbitrary unit) at 488 nm by argon-ion laser was
measured as the relative intracellular Ca
2  ion con-
centration [Ca
2 ]i. All data are expressed as the
means9SEM. All experiments were conducted at
248C.
Biotin-switch assay for culture cell lysates
For the S-nitrosylation assay in living cells, human
embryonic kidney (HEK) 293 cells (ATCC) were
transfected with one of TRPV4WT/pcDNA3.1,
TRPV4(C853A)/pcDNA3.1, or pcDNA3.1 alone
or with either of CaM/pcDNA3.1 or CaM1234/
pcDNA3.1 using ExGen500 (Fermentas) in accordance
with the manufacturer’s instructions. After 24 36 h
after transfection, the cells were collected and lysed in
HEN buffer containing 0.5% Triton X-100. The cells
were treated for 15 min with 0.5 mM NOBF4, washed
twice in phosphate-buffered saline, collected, and lysed
in HEK 293 cells with 0.5% Triton X-100, in accor-
dance with the manufacturer’s recommendations (S-
Nitrosylated Protein Detection Kit, Cayman Chemical
Co.)
Patch clamp experiments
HEK 293 cells were transfected either with TRPV
4WT/pcDNA3.1, TRPV4 (C853A)/pcDNA3.1, or
pcDNA3.1 using ExGen500 (Fermentas) according to
the manufacturer’s instructions. The expressed TRPV4
currents were recorded via a whole cell patch clamp
technique using an Axopatch 200B amplifier (Axon
Instruments) as previously described. The pCLAMP
software (version 8.0, Axon) was used to generate
voltage-pulse protocols and to acquire and analyze the
data. TRPV4 currents were elicited by 2-s test pulses
(Vt) to  60 mV followed by 2-s repolarization pulses
to -40 mV from a holding potential (Vh) of -65 mV at
0.1 Hz. Peaks of tail current amplitude were measured
during the repolarization pulse. All experiments were
conducted at a room temperature of 22928C. Pipette
solution contained (in mM), 110 aspartic acid, 1 CaCl2,
1 MgCl2, 5 ATP potassium salt, 10 HEPES, 11 EGTA
(pH 7.3 adjusted with KOH): in some experiments, 11
mM EGTA was replaced with equimolar BAPTA to
maintain low concentrations of intracellular Ca
2 .
The external (bath) solution was Tyrode’s solution
containing (in mM), 135 NaCl, 4.8 KCl, 2 CaCl2, 1.2
MgCl2, 5 glucose, and 10 HEPES (pH 7.4 adjusted
with NaOH).
Statistics
All numerical values are presented as means9SE.
Statistical significance was evaluated via an analysis
of variance followed by Bonferroni’s multiple compar-
ison test. PB0.05 was established as the significance
level.
Results
Specific S-nitrosylation on the TRPV4 Cys
853 residue
Several ion-channel regulations have been shown to
occur as the result of S-nitrosylation, including the
cyclic nucleotide-gated channel and the delayed recti-
fier potassium channel (Choi et al. 2000; Sun et al.
2001, 2007; Yoshida et al. 2006; Asada et al. 2009).
TRPC5 (including other TRP channels) is also acti-
vated by NO via cysteine S-nitrosylation, as a general
mechanism for the regulation of stimulus-coupled
cellular Ca
2  flux (Teixeira et al. 2008; Yoshida et al.
2006; Olson and Garba ´n 2008).
After recognizing the putative S-nitrosylation site
(Cys
853 residue) of TRPV4 with the consensus se-
quence information (Lys/Arg/His/Asp/Glu)Cys(Asp/
Glu) (sites  1, 0, and  1, respectively), we investi-
gated its S-nitrosylation and its biological significance
(Figure 1A). We attempted to pinpoint the target Cys
residue for S-nitrosylation on Cys
645 of Val/Cys/Asp
or Cys
853 of Lys/CysAsp in human TRPV4. We
focused first on Cys
853, because of its greater similar-
ity with the consensus sequence than Cys
645.W e
determined whether TRPV4 is modified by NO via
S-nitrosylation using a Biotin-Switch Assay (Figure
1B and C). To corroborate Cys
853 as the principal
target of S-nitrosylation, we expressed His-tagged full-
length TRPV4 in which Cys
853 had been replaced with
Ala, leaving the remaining Cys
853 intact (TRPV4
C853A) in HEK293 cells (Figure 1B). The cell lysates
(left panel) were treated with 0.5 mM NOBF4 for 15
min, and subjected to biotin-switch assay (right
panel). As shown in Figure 1B, the application of
an NO donor induced S-nitrosylation of TRPV4 WT
(lane 3) but not C853A (lane 2). Thus, these results
confirmed that TRPV4 is modified by NO as
S-nitrosylation, and its Cys
853 is the principal target
of S-nitrosylation. However, the S-nitrosylation of
TRPV4 mutant (C645A, which is located at the
extracellular side near its pore region) was unchanged
(data not shown), even though Cys
645 was also
proposed by other researchers as a putative S-nitro-
sylation site. As a consequence, S-nitrosylation de-
tected TRPV4 WT (lane 3 Figure 1B), but was
completely eliminated for the C853A mutant (lane 2,
Figure 1B).
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853 residue of
TRPV4 is the specific site for the S-nitrosylation,
we used the GST- TRPV4 (aa 718-871) fusion protein
expressed in E. coli (Figure 1C). The purified
proteins, 2 g/ml of WT or C853A fusion protein in
HEN buffer (left panel Figure 1C), were treated with
0.5 mM NOBF4 for 1 h and subjected to biotin-
switch assay (right panel in Figure 1C). As shown in
Figure 1C, the application of an NO donor induced
S-nitrosylation of TRPV4 WT (lane 3 in right panel)
but not C853A (lane 2 in right panel). Together these
results in Figure 1 B and C also confirmed that
TRPV4 is modified by NO as S-nitrosylation on its
Cys
853 residue, consistent with the expectation from
Figure 1A.
TRPV4 C853A inhibits the protein protein interaction
with calmodulin, and affects its subcellular localization
One protein known to be involved in the feedback
regulation of a variety of ion channels is calmodulin
(CaM) (Nilius et al. 2003; Strotmann et al. 2003; Earley
et al. 2005). The CaM binding site is known to be
located within the C-terminal domain of TRPV4 (aa
718 871). In order to determine whether the
S-nitrosylation on the Cys
853 residue affects the bind-
ing between TRPV4 and CaM, GST-fusion proteins
encompassing the C-terminal TRPV4 domains were
constructed and expressed in E. coli. Approximately 2
g/ml of WT or C853A fusion protein bound to
glutathione-Sepharose was incubated with HEK293
Figure 1. The S-nitrosylation of TRPV4. (A) The putative S-nitrosylation site was noted in human TRPV4 (Cys
853). Cys
853
(
852KCD
855) was replacedwith alanine (C853A). Among 14 Cys residues in TRPV4, the Cys
853 residue is followed immediately by
the acidic amino residue (Lys/Arg/His/Asp/Glu)Cys(Asp/Glu) (sites  1, 0, and  1, respectively) which is required for S-
nitrosylation by nitric acid (NO). Shaded blocks denote the N-terminal ankyrin repeats and the transmembrane helices.
Underlines indicate the C-terminal cytoplasmic region (aa718 871) which is expressed in E. coli as GST fusion protein. The
TRPV4 Cys
853 which is replaced with alanine is marked with an arrow. (B) HEK293 cells expressing His-tagged TRPV4 WT,
TRPV4 (C853A) with 0.5 mM NOBF4. The cell lysates were prepared and subjected to biotin-switch assay. The left panel is the
representative data for immunoblotting with an anti-His antibody and biotin antibody. The number at the bottom represents the
density relative to TRPV4 WT. (C) GST fusion proteins with TRPV4 fragments containing Cys
853 (as shown in A) were prepared
from E. coli, and subjected to biotin-switch assay. GST fusion proteins with TRPV4 fragments harboring Cys
853 were prepared
from E. coli, and subjected to the biotin-switch assay. The density relative to TRPV4 WT is shown at the bottom.
98 E.J. Lee et al.cell lysates with/without treatment with 0.5 mM
NOBF4 for 1 h. As is shown in Figure 2A, the pull-
down of CaM by TRPV4 WT from the HEK293 cell
lysates was affected by the treatment of 0.5 mM
NOBF4, but C853A did not affect it.
Considering that TRPV4 can be S-nitrosylated at
its CaM binding site and is then unable to bind to
Ca
2 -CaM, we wondered whether a fraction of the
expressed wild-type channels had already been S-
nitrosylated. These channels would then prove unable
to bind to Ca
2 -CaM and would consequently reduce
the effect of Ca
2 -CaM binding disruption. If this is
indeed the case, all of the expressed C853A mutant
TRPV4 channels that cannot be S-nitrosylated at their
CaM-binding site should be capable of binding to
Ca
2 -CaM and should therefore show more activation
than the wild-type channels. Thus, these results sug-
gested that the S-nitrosylation of TRPV4 and Ca
2 -
CaM binding in the activation state are mutually
exclusive.
In an effort to determine whether the Cys
853 residue
change of TRPV4 C853A is attributable to its sub-
cellular localization or to a deviation in CaM binding
at the expression level, we conducted a confocal
microscopic examination of TRPV4 WT, C853A, or
with CaM. TRPV4 WTwas principally detected within
the plasma membrane, whereas TRPV4 C853A was
primarily detected in the cytoplasm (Figure 2B).
Furthermore, we noted that a significant difference in
TRPV4 WT subcellular localization could be distin-
guished with/without the treatment of 0.5 mM NOBF4
for 30 min. The co-localization of TRPV4 WT and
CaM was disrupted principally in the cytoplasm by the
treatment of 0.5 mM NOBF4 for 30 min (compare the
top two lanes), but that of C853A and CaM was not
changed with/without NOBF4 treatment (compare the
bottom two lanes).
Taken together, these results showed that the Cys
853
residue of TRPV4 (by NO through S-nitrosylation)
appears to be the control point which binds with CaM
and contributes its plasma membrane localization.
Muation of the S-nitrosylation site (C853A) of TRPV4
enhances its activity and the sensitization to 4-a PDD
We employed a patch clamp experiment to evaluate the
functional consequences of the S-nitrosylation of
Cys
853 of the TRPV4 channel. HEK 293 cells express
TRPV4 and conduct slowly activating outward cur-
rents. As is shown in Figure 3A, the single channel
current elicited in the TRPV4 WT was recorded. We
observed that the application of NOBF4 (at 50 mM)
decreased the relative channel activity of the TRPV4 by
approximately 1/4-fold from 24.892.51 to 4.1290.23
pA (Figure 3A upper lane, n 6), whereas NOBF4 did
not change the TRPV4 C853A channel activity
(Figure 3A bottom lane, n 6). Further, the channel
open probability (PO) declined in the TRPV4 WT
(Figure 3A upper lane, PO 0.1890.02) to less than 1/5
the PO of TRPV4 C853A (Figure 3A bottom lane, PO
0.9590.31), after treatment with NOBF4. Comparing
with the properties of TRPV4 WT, the amplitude and
PO of TRPV4 C853Awere unchanged with the NOBF4
treatment (Figure 3A bottom). However, with the
infusion of 1 M 4-a PDD (a known PKC-independent
TRPV4 activator; Watanabe et al. 2002, 2003; Birder
et al. 2007; Fernandes et al. 2008;), the channel
open probability (PO) elicited in the TRPV4 C853A
(Figure 3A bottom lane, PO,0.9590.31) was more than
5 times that of TRPV4 WT (Figure 3A upper lane, PO
0.1890.02), and the relative channel activity of the
TRPV4 C853A was enhanced approximately 3-fold
(from 11.290.2 to 23.892.5 pA, n 6), with the
application of 4-a PDD (Figure 3A). Thus, the single
channel activity of the TRPV4 C853A mutant was
increased as compared with the WT, thereby support-
ing the notion that the S-nitrosylation on its Cys
853
residue is a major regulation for the direct TRPV4
channel inactivation.
Next, to obtain more information regarding the
role of Cys
853 S-nitrosylation, we compared the whole
cell current property with TRPV4 WT and the TRPV4
C853A mutant (Figure 3B). As expected from the
single channel current in Figure 3A, the current elicited
in the TRPV4 WT was decreased from 2592 pA/pF
(n 6) to 1793 pA/pF with NOBF4 treatment
(Figure 3B left), even though the current elicited in
the TRPV4 C853Awas almost unchangedwith NOBF4
treatment (1692 pA/pF, n 6, Figure 3B right). Thus,
those results also supported the idea that the activity of
the TRPV4 channel is regulated by the S-nitrosylation
on its Cys
853 residue as a negative effect. Unexpectedly,
however, the current induced by 1 mMo f4 - a PDD
showed a dramatic difference between TRPV4 WT and
C853A (Figure 3B upper lane, TRPV4 WT, 10698 pA/
pF, n 6, C853A: 150914 pA/pF, n 6), suggesting
that TRPV4 C853A was more sensitive than TRPV4
WT to 4-a PDD. Therefore, other regulation mechan-
isms, including protein protein interaction with the C-
terminal domain of TRPV4 (see the next discussion
section), seem to be required.
Ca
2 image analysis of TRPV4 WT and C853A with
4-a PDD stimulation
It has been proposed that TRPV4 may form constitu-
tively open ion channels that show an inwardly rectify-
ingcurrent-voltagerelationshipwithahighselectivityof
calcium over monovalent cations (Strotmann et al.
2003; Suzuki et al. 2003a; Cuajungco et al. 2006;
Animal Cells and Systems 99100 E.J. Lee et al.Fernandes et al. 2008). Additionally, their activity has
been correlated with the electrochemical driving force
for Ca
2  and the level of intracellular Ca
2  ([Ca
2 ]i),
which is suggestive of the existence of calcium-depen-
dent regulatory mechanisms. In order to determine the
consequences of S-nitrosylationonthe Cys
853residueof
TRPV4, we employed a Ca
2  image experiment
(Figure 4). With the transfection of TRPV4 WT, or
C823A, the application of 4-a PDD increased the
current amplitudes of TRPV4 (Figure 3). Although
the recombinant TRPV4 expression elicited a robust
elevation of [Ca
2 ]i in response to 4-a PDD treatment
of HEK 293 cells, the difference was as dramatic in
TRPV4 (Figure 4). Comparing the optical response
change (as arbitrary [Ca
2 ]i concentration) of TRPV4
C823Awith that of WT at a given time period (30 min)
of 1 mM4 - a PDD treatment, it shows a 3.3 times higher
[Ca
2 ]i than does TRPV4 WT (Figure 4). Interestingly,
[Ca
2 ]i of TRPV4 C823A fluctuated without declining
to the base level (Figure 4), thereby suggesting that
TRPV4 C823A is in the active stage without the
inactivation step. However, the representative trace of
TRPV4 WT showed a regular response signal to 4-a
PDD (Figure 4 left). The response of TRPV4 WT to 4-a
PDD showed a regular up-and-down change, whereas
TRPV4 C853A did not respond in this fashion (Figure
4).
Consistent with the electrophysiology results shown
in Figure 3, we also noted that TRPV4 C853A
contributed 3 times the Ca
2  entry as compared to
TRPV4 WT within a given time period (30 min) in 1
mM4 - a PDD treatment (Figure 4). Comparing the
inactivation pattern of TRPV4 WT (Figure 4 left) with
that of C853A (Figure 4 right), TRPV4 C853A appears
to be activated, thereby suggesting that the mutation of
Cys
853 to Ala is relevant to the activation step of this
channel protein.
In summary, these results showed that TRPV4 is
modulated by S-nitrosylation on its Cys
853, one of its
authentic S-nitrosylation proteins. As a consequence of
the S-nitrosylation on the Cys
853 of TRPV4, the reduc-
tion in Ca
2  channel activity was coupled to a
prolongationoftheinactivestate(Figure5).Meanwhile,
TRPV4 C853A mutant seems to be an active form, with
increased sensitivity to 4-a PDD.
DISCUSSION
An abundant variety of stimuli activate members of the
various TRPV subfamilies. Vanilloid compounds such
as capsaicin, the compound responsible for the spici-
ness of hot chili peppers, but also moderate heat and
protons can activate TRPV4 channels, which function
as an integrator of a variety of painful stimuli. Further,
TRPV4 is sensitive to noxious heat and can be
constitutively activated by growth factors (Nilius
et al. 2003; Strotmann et al. 2003; Cohen 2006;
Vennekens et al. 2008; Everaerts et al. 2009).
In this study, we demonstrate that an NO donor
induces S-nitrosylation at Cys
853 in the C terminus of
TRPV4 (Figures 1 and 5). Our results provide convin-
cing evidence to suggest that the Cys
853 residue of
TRPV4 is required for site-specific S-nitrosylation
(Figure 1). Further, S-nitrosylation at the Cys
853
residue in the TRPV4 channel functionally and directly
regulates its channel sensitivity. Here, we proposed that
NO conversely inhibits the Ca
2  response and direct
S-nitrosylation on the Cys
853 of TRPV4 as a negative
feedback regulation (Figure 5). These findings reveal
the structural motif for the NO-sensitive activation gate
in TRP channels, and indicate that NO sensors are a
new functional category of cellular receptors extending
over different TRP families. Among 14 Cys residues in
human TRPV4, the Cys
853 residue is immediately
followed by the acidic amino residue, and the in vitro
biotin-switch assay indicates that the presence of acidic
amino acid at the (Lys/Arg/His/Asp/Glu)Cys(Asp/Glu)
(sites  1, 0, and  1, respectively) residue is required
for the S-nitrosylation of Cys
853 (Figure 1).
It was demonstrated previously that endothelial
NO synthase and TRPV4 co-localize in the caveolar
fraction of guinea pig hearts, thereby indicating the
close proximity of the NO donor and the target
protein. Thus, multiple factors are responsible for
making the Cys
853 of TRPV4 a target of molecule-
specific and site-specific S-nitrosylation. This may
Figure 2. Effects of S-nitrosylation on the interaction between TRPV4 with calmodulin. (A) Representative superimposed
TRPV4 currents without (upper panel) and with (lower panel) NO infusion. HEK293 cells were transiently transfected with His-
TRPV4 WT or C853A plasmid. After 48 h, the cells were lysed, total proteins were re-collected, and immunoprecipitation was
conducted with nickel beads. Western blot assays were then conducted with a rabbit TRPV4 Ab or an anti-CaM antibody in
HEK293 cell. The number at the bottom represents the density to relative TRPV4 WT. (B) Effects of S-nirosylation on the
subcellular localization of TRPV4 and calmodulin. The subcellular localization of TRPV4 WT, TRPV4 C853A or C823A in
HEK 293 cells with/without NO infusion. Confocal microscopic analyses of transfected His-TRPV4 WT, or mutant (C853A, all
constructs are shown in green) were conducted in order to determine whether it mergedwith CaM (shown in red). The transfected
HIS-TRPV4 WTwas merged (yellow) without NO infusion (top two columns). However, the transfected HIS-TRPV4 C853Awas
not merged with CaM (bottom two column) with/without NO infusion. His-TRPV4 WT was principally detected within the
plasma membrane, whereas HIS-TRPV4 C853A was primarily detected in the cytoplasm.
Animal Cells and Systems 101Figure 3. Effects of S-nitrosylation of TRPV4 on its channel current. (A) Representative superimposed TRPV4 WT currents
without (upper panel) and with (lower panel) infusion of NO. The black trace represents the basal current, the green trace
represents the presence of NOBF4, 100 nM, and the blue trace represents post-washout of NOBF4. HEK 293 cells were
transfected with either TRPV4 WT/pcDNA3.1 or TRPV4 (C853A)/pcDNA3.1, using ExGen500 (Fermentas) in accordance with
the manufacturer’s instructions. Expressed TRPV4 currents were recorded with a patch clamp technique using an Axopatch 200B
ampliﬁer (Axon Instruments). pCLAMP software (version 8.0, Axon) was used to generate voltage-pulse protocols and for data
acquisition and analysis. TRPV4 currents were elicited by 2-s test pulses (Vt) to  60 mV followed by 2-s repolarization pulses to -
40 mV from a holding potential (Vh) of -65 mVat 0.1 Hz. (B) (Upper panel) Current-voltage relations of peak whole-cell cationic
currents recorded from different HEK293 cells transfected with TRPV4-WT, or TRPV4-C853A and exposed to 1 mM a 4PDD,
then again dialyzed with normal buffer again. Normalized (pA/pF) current traces in response to avoltage step to -100 mV for the
wild-type (WT) and C853A constructs. All experiments were conducted at 248C. (Lower panel) Mean current densities (9S.E.) at
 60 mV in HEK293 cells expressing TRPV4-WT (n 6), and TRPV4 C853A (n 6) and dialyzed with 1 mM4 - a PDD or
NOBF4.*PB0.05 versus to the control. ** PB0.05 versus to TRPV4 WT.
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intracellular milieu, the presence of NO is required.
The S-nitrosylation of the TRPV4 channel is a novel
regulatory mechanism of this channel, which may have
a profound impact on the physiological regulation of
cardiac electrical sensitivity, as the Ca
2  channel
composed of TRPV4 has been identified to perform
a crucial regulatory function in cardiac electrophysiol-
ogy, including responses to autonomic nervous stimu-
lation and adaptation to changes in heart rate. Even
though it has been reported that TRPV5 and TRPV6
are tightly controlled by the membrane potential,
including a voltage-dependent open-pore block by a
Ca
2 -dependent feedback mechanism, it is not known
that TRPV4 is also regulated as the same manner. The
S-nitrosylation of the TRPV4 channel seems to be
one of the Ca
2 -dependent feedback mechanisms
(Figure 5).
Interestingly, we noted that the sensitivity of the
C853A mutant to 4-a PDD is higher than that of WT
(Figures 3 and 4). However, we do not at present know
the reason for this phenomenon; rather, it appears
that the S-nitrosylation of TRPV4 Cys
853 residue
prevents the access of 4-a PDD to the channel. The
mechanism underlying the S-nitrosylation-induced in-
activation of the TRPV4 channel also remains to be
addressed. Biochemical, spectroscopic and crystallo-
graphic analyses have provided the structural model for
the C-terminal region of TRPV4 binding sites for NO.
Although the functional assembly of TRPV4 channels
has been demonstrated to require its interaction with
NO, similar TRPV4 channel currents were recorded in
the absence and presence of NO co-expression. En-
dogenous levels of NO in HEK293 cells were approxi-
mately one-eighth of those in NO-transfected cells,
which may prove sufficient for the functional assembly
of TRPV4, but not for TRPV4 S-nitrosylation. Cer-
tainly, more work will be necessary to decipher the role
of NO in S-nitrosylation and the mechanism linking
the S-nitrosylation of the TRPV4 channel to its
regulation. The mechanism of TRPV inactivation by
Ca
2  in general has yet to be clearly elucidated.
Figure 4. Effects of WTor C853A on TRPV4 intracellular calcium concentration change ([Ca
2 ]i. Representative trace showing
the effect of 1 mM4 - a PDD in TRPV4 WT or C853A transfected or His vector-transfected (mock) HEK 293 cells. Summary of
[Ca
2 ]i, expressed as the absorption (in arbitrary units) at 488 nm (argon-ion laser), after 4-a PDD in HEK 293 cells. The
ﬂuctuation caused by 4-a PDD is expressed as means9SE: numbers of cells examined are indicated above each column.
Responses (with the arbitrary units) were measured as the total area of each representative trace from 10 min to 35 min minus
each basal total area of the same period. All experiments were conducted at 248C. * PB0.05 versus TRPV4 WT.
Animal Cells and Systems 103Mutant channels, harboring a single mutation in the C-
terminus of TRPV4 (E797A), are constitutively open
(Nilius et al. 2003). Such mutants increase [Ca
2 ]i in
non-stimulated cells. It is likely that this constitutive
activation reflects a defect in the inactivation of Ca
2 .
We do not at present know whether (E797A) also
affects the S-nitrosylation of TRPV4, or whether its
C853A mutant is also defective in inactivating its
channel activity, like E797A. However, even though it
remains unclear as to how the C853A mutant affects its
activation, it is probably modulated by NO and may
prove essential for the regulation of the inward driving
force for Ca
2  entry (Figure 5).
Recombinant TRPC1, TRPC4, TRPV4, TRPV1,
TRPV3 and TRPV4 of the TRPC and TRPV families,
which are commonly classified as receptor-activated
channels and thermosensor channels, induce Ca
2 
entry into cells in response to nitric oxide (NO)
(Yoshida et al. 2006; Miyamoto et al. 2009). Even
though our data demonstrate that the cytoplasmically
accessible Cys
853 is an S-nitrosylation site that mediates
NO sensitivity in TRPV4, the other responsive TRP
proteins have conserved cysteines on the same N-
terminal side of the pore region. In living cells, an
NO donor failed to S-nitrosylate TRPV4 in the
presence of NO (Miyamoto et al. 2009), implying
that both the redox motif flanking Cys
853 and the
absence of NO are required. Infusions of NO are
required for the S-nitrosylation of TRPV4 in living
cells, but not in the cell lysates.
It has been reported that the nitrosylation of native
TRPV4 upon G protein-coupled ATP receptor stimu-
lation elicits Ca
2  entry into endothelial cells. In the
case of TRPV4, however, even though the increase of
NO in the cells also appears to enhance the nitrosyla-
tion of native TRPV4, the nitrosylation site (Cys
853)o f
TRPV4 is located in its C-terminal tail, and the Ca
2 
transport by the channel appears to be inactivated by
this modification, as a negative feedback Ca
2  trans-
port regulation mechanism (Figures 1 and 5).
Yoshida et al. predicted that the NO responsiveness
of TRPV4 channels is localized to its Cys
645 residue in
(
644VCD
646) by the alignment of amino acid sequences
surrounding the Cys
553 and Cys
558 of TRPC5 with
counterpart sequences, including TRPC1 and TRPC4,
as well as the thermosensor channels TRPV1, TRPV3
and TRPV4, which harbor conserved cysteines on the
N-terminal side of the H7 putative pore-forming region
in the linker region located between the fifth and sixth
transmembrane domains S5 and S6 (Yoshida et al.
2006). However, the actual S-nitrosylation site of
human TRPV4 is not the Cys
645 residue (
644VCD
646)
Figure 5. Schematic representation for the regulation of TRPV4 by S-nitrosylation on its Cys
853 residue. When the normal cell
receives the proper stimuli, such as mechanical, chemical, heat or nociception stimuli, the outside Ca
2  enters the cell through
TRPV4. The entered Ca
2  stimulates eNOS, which produces NO. The increased NO then S-nitrosylates the Cys
853 residue of
TRPV4, and dissociates the activator proteins that bind to its C-terminal region (such as Ca
2 -CaM), resulting in the
inactivation of TRPV4 (as a negative feedback regulation). The TRPV4 desensitized (inactivated) by S-nitrosylation returns to
the active state via denitrosylation, the mechanisms for which currently remain unknown. The cells that contain mutant C853A
do not properly respond to NO, even though the outside Ca
2  enters the cell through the TRPV4 channel upon stimulus, and
increases the concentration of NO via the activation of eNOS. However, the S-nitrosylation (inactivation) of the TRPV4 C853A
mutant is blockaded, as it cannot receive nitric oxide on its Cys
853 residue. Thus, the TRPV4 C853A mutant appears to remain in
an active state for a longer period than TRPV4 WT.
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forming region found between the fifth and sixth
transmembrane domains, but rather the Cys
853 residue
(
852KCD
855) in its intracellular C-terminal domain
(Figure 1). Therefore, the S-nitrosylation site among
TRP family proteins appears to show protein specifi-
city.
We evaluated our hypothesis as described in Figure
5, and our observations indicated that TRPV4 is
modulated by S-nitrosylation (dependent on a Ca
2 
ion) as a negative feedback regulation loop. In a short-
term regulation loop, TRPV4 WT appears to be
modulated by the association of regulatory proteins
(such as Ca
2 -bound CaM) on its C-terminal cyto-
plasmic domain. At first, the naive TRPV4 begins to
open in response to several over-threshold environ-
mental signals (e.g. mechanical, chemical temperature,
osmolality). The activated TRPV4 is positively acti-
vated by bound regulatory proteins such as CaM, at
low levels of Ca
2  ion concentration. However, at high
Ca
2  ion levels, the fully active TRPV4 is inhibited by
negative feedback and returned to the inactive form, as
negative feedback regulatory loop by NO (S-nitrosyla-
tion) (Figure 5). The NO is putatively generated by
eNOS under high Ca
2  ion concentration conditions.
This phenomenon also explains our observation that,
after activation with 4-a PDD, TRPV4 WT showed
oscillations in the concentration of the Ca
2  ion in the
cytoplasm [Ca
2 ]i (Figure 4 left). On the other hand,
TRPV4 WT is S-nitrosylated on its Cys
853 residue by
NO, which remains inactive until being de-nitrosylated
on its Cys
853 residue and the association of a putative
regulatory protein (such as CaM). Consistent with this
assumption, we noted high Ca
2  channel activity with/
without 4-a PDD treatment (see Figures 3 and 4),
abrogating the interaction of the protein with the
activation factor. This model also explains, to some
degree, why the TRPV4 E797 mutant is constitutively
active (Nilius et al. 2003).
In conclusion, we demonstrated herein that NO can
control the selective and direct activation of the
TRPV4 channel. This novel negative regulatory me-
chanism of the Ca
2 channel by NO (Figure 5) may
perform a role in the TRPV4-mediated cell signal
phenomenon in which homeostasis is maintained
to prevent the apoptosis induced by Ca
2  toxicity
during the response to intracellular Ca
2 .
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